neoANT-HILL: an integrated tool for identification of potential neoantigens
Abstract Background Cancer neoantigens have attracted great interest in immunotherapy due to their capacity to elicit antitumoral responses. These molecules arise from somatic mutations in cancer cells, resulting in alterations on the original protein. Neoantigens identification remains a challengin...
Main Authors: | Ana Carolina M. F. Coelho, André L. Fonseca, Danilo L. Martins, Paulo B. R. Lins, Lucas M. da Cunha, Sandro J. de Souza |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-02-01
|
Series: | BMC Medical Genomics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12920-020-0694-1 |
Similar Items
-
Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma
by: Tanner M. Johanns, et al.
Published: (2019-04-01) -
Utilizing immunogenomic approaches to prioritize targetable neoantigens for personalized cancer immunotherapy
by: Ravi K. Shah, et al.
Published: (2023-12-01) -
ProGeo-neo: a customized proteogenomic workflow for neoantigen prediction and selection
by: Yuyu Li, et al.
Published: (2020-04-01) -
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
by: Zhi Pang, et al.
Published: (2023-12-01) -
Identification and Targeting of Mutant Peptide Neoantigens in Cancer Immunotherapy
by: Daniel J. Verdon, et al.
Published: (2021-08-01)